U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929533) titled 'Pharmacogenomics-Supported Psychotropic Prescribing Trial' on March 27.
Brief Summary: Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in inpatient psychiatry clinics in Manitoba.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Mental Disorder
Pharmacogenetics
Adverse Drug Reaction (ADR)
Effectiveness
Intervention:
DIAGNOSTIC_TEST: Pharmacogenetic Testing
Participants will donate a 1ml (one-fifth of a teaspoon) sample of saliva. DNA extracted from the saliva sample will be used for genotyping. Genotyping results wil...